Frequently Asked Questions
The market is segmented based on , By Services Outlook (Regulatory Consulting, Legal Representation, Regulatory Writing and Publishing, Product Registration, Clinical Trial Applications and Other Services), Size (Small, Medium and Large), Category (Drugs, Generics, Innovators, Biologics, Biotech, ATMPs, Medical devices, Therapeutic and Diagnostic), Indication (Oncology, Neurology, Cardiology, Immunology and Others), Stage (Preclinical, Clinical and PMA (Post Market Authorization), End-User (Medical Device Companies, Pharmaceutical Companies and Biotechnology Companies) – Industry Trends and Forecast to 2030.
.
The Global Regulatory Affairs Outsourcing Market size was valued at USD 9389.20 USD Million in 2022.
The Global Regulatory Affairs Outsourcing Market is projected to grow at a CAGR of 10.66% during the forecast period of 2023 to 2030.
The major players operating in the market include Accell Clinical Research LLC, Genpact, CRITERIUM , PRA Health Sciences, Promedica International, WuXiAppTec, Medpace, PPD , Charles River Laboratories, ICON plc, Covance, Parexel International Corporation, Freyr, Navitas Clinical Research , Medelis , Sciformix, Tech Tammina, Acorn Regulatory Consultancy Services , BIOMAPAS, REGULATORY PROFESSIONALS, CompareNetworks .
The market report covers data from the U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa.
